AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5
slide-6

Euglim-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Bayer Zydus Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Euglim-M 1 Tablet PR

Diabex Duo, a single-dose tablet, is an antidiabetic medication combining two active ingredients for managing type 2 diabetes in adults. It regulates blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management, as directed by your doctor. Lifestyle choices are integral to diabetes control. Commonly reported is hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption increases hypoglycemia risk and should be minimized. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabex Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Euglim-M 1 Tablet PR

The information is unavailable.

Uses of Euglim-M 1 Tablet PR

Managing Type 2 diabetes

Major Benefits of Euglim-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Euglim-M 1 Tablet PR with a meal.

Common Side effects of Euglim-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Euglim-M 1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Administer one Euglim-M tablet (PR) with a meal.

How Euglim-M 1 Tablet PR works:

Euglim-M 1 Tablet PR combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Euglim-M 1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Euglim-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Euglim-M 1 Tablet PR. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Euglim-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consult your physician for guidance. Euglim-M 1 Tablet PR is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Euglim-M 1 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, Euglim-M 1 Tablet PR initiation should begin with a low dose; however, its use is contraindicated in individuals with severe liver disease.

What if you forget to take Euglim-M 1 Tablet PR :

Should you forget to take a Euglim-M 1 Tablet PR, administer it immediately if you remember. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Euglim-M 1 Tablet PR

LabelValue
Potential for Dependence None.
Treatment Category Diabetes medication

FAQs on Euglim-M 1 Tablet PR

Retain this medication within its original, securely sealed container or packaging. Follow the storage directions printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Indeed, Euglim-M 1 Tablet PR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more prevalent in individuals with pre-existing kidney impairment, the elderly, or those who consume significant amounts of alcohol. Warning signs of lactic acidosis can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Euglim-M 1 Tablet PR and seek prompt medical attention.
Euglim-M 1 Tablet PR, a dual-drug formulation containing glimepiride and metformin, is indicated for managing type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when combined with a suitable diet and regular physical activity. Glimepiride's mechanism involves stimulating insulin secretion from the pancreas, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose production and enhancing insulin responsiveness. This specific combination is unsuitable for treating type 1 diabetes mellitus.
Taking Euglim-M 1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), changes in taste perception, queasiness, abdominal discomfort, loose stools, and cephalalgia. Rare but potentially serious adverse reactions include lactic acidosis. Prolonged administration might result in a Vitamin B12 deficiency.
Indeed, prolonged administration of Euglim-M 1 Tablet PR can lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive strategies proposed by some investigators involve supplemental Vitamin B12 at least annually.
Indeed, taking Euglim-M 1 Tablet PR can lead to hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar may include nausea, headache, irritability, increased hunger, sweating, lightheadedness, rapid heartbeat, and feelings of anxiety or tremor. The risk is heightened by skipped or delayed meals, alcohol consumption, excessive physical activity, or concurrent use of other diabetes medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available simple carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Consuming alcohol concurrently with Euglim-M 1 Tablet PR is inadvisable due to the risk of dangerously low blood sugar (hypoglycemia). Furthermore, this combination may heighten the likelihood of lactic acidosis.
Euglim-M 1 Tablet PR
74
MRP 90
17% off